相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's Disease
Nicolas Pierre et al.
JOURNAL OF CROHNS & COLITIS (2020)
Small Bowel Healing Detected by Endoscopy in Patients With Crohn's Disease After Treatment With Antibodies Against Tumor Necrosis Factor
Kento Takenaka et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice
Javier P. Gisbert et al.
JOURNAL OF CROHNS & COLITIS (2020)
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine
Yalong Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
P043 Small intestinal inflammation but not colitis drives pro-inflammatory nutritional antigen-specific T-cell response
Y Rodríguez Sillke et al.
Journal of Crohns & Colitis (2020)
Membrane mucins of the intestine at a glance
Thaher Pelaseyed et al.
JOURNAL OF CELL SCIENCE (2020)
An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease
Jan Wehkamp et al.
FRONTIERS IN IMMUNOLOGY (2020)
Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans
Connie W. Y. Ha et al.
CELL (2020)
An interspecies translation model implicates integrin signaling in infliximab-resistant inflammatory bowel disease
Douglas K. Brubaker et al.
SCIENCE SIGNALING (2020)
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Raja Atreya et al.
FRONTIERS IN MEDICINE (2020)
Expansion of IL-23 receptor bearing TNFR2+T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease
Heike Schmitt et al.
GUT (2019)
T-cell Composition in Ileal and Colonic Creeping Fat - Separating Ileal from Colonic Crohn's Disease
Lea I. Kredel et al.
JOURNAL OF CROHNS & COLITIS (2019)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Petra Bacher et al.
CELL (2019)
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence
Matthieu Allez et al.
GUT (2019)
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
Julie Schulthess et al.
IMMUNITY (2019)
Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?
Parambir S. Dulai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances
Sebastian Zundler et al.
GUT (2019)
Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells
Alexander Visekruna et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
Lyssia Belarif et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease
Claudia Guenther et al.
GASTROENTEROLOGY (2019)
Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
Silvio Danese et al.
GASTROENTEROLOGY (2019)
The Roles of Peyer's Patches and Microfold Cells in the Gut Immune System: Relevance to Autoimmune Diseases
Nobuhide Kobayashi et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease
Ren Mao et al.
INFLAMMATORY BOWEL DISEASES (2019)
The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response
Sydney Lavoie et al.
ELIFE (2019)
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
Floris Imhann et al.
GUT (2018)
Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease
Leonardo Guizzetti et al.
JOURNAL OF CROHNS & COLITIS (2018)
DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome
Kate Joanne Howell et al.
GASTROENTEROLOGY (2018)
Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study
Sudha Visvanathan et al.
JOURNAL OF CROHNS & COLITIS (2018)
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
Paulo G. Kotze et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease
Ta-Chiang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease
Raja Atreya et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Blockade of αEβ7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo
Sebastian Zundler et al.
GUT (2017)
Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?
Sreedhar Subramanian et al.
GUT (2017)
Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease
Thaddeus S. Stappenbeck et al.
GASTROENTEROLOGY (2017)
The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo
Sebastian Zundler et al.
INFLAMMATORY BOWEL DISEASES (2017)
P675 Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission in Crohn's disease and ulcerative colitis – 54 week data
T. Molnár et al.
Journal of Crohns & Colitis (2017)
Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis
Markus Tschurtschenthaler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
Brian G. Feagan et al.
LANCET (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
Gilles Duvoisin et al.
MEDIATORS OF INFLAMMATION (2017)
A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia
Thomas Suply et al.
SCIENCE SIGNALING (2017)
Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action
Judith Raschig et al.
PLOS PATHOGENS (2017)
A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia
Thomas Suply et al.
SCIENCE SIGNALING (2017)
A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15
Borja Ocon et al.
FRONTIERS IN IMMUNOLOGY (2017)
Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease
Gwendalyn J. Randolph et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
Gaik W. Tew et al.
GASTROENTEROLOGY (2016)
Leukocyte Trafficking to the Small Intestine and Colon
Aida Habtezion et al.
GASTROENTEROLOGY (2016)
Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease
Timna Naftali et al.
INFLAMMATORY BOWEL DISEASES (2016)
Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype
Andrea D. Tyler et al.
INFLAMMATORY BOWEL DISEASES (2016)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Isabelle Cleynen et al.
LANCET (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Immunological aspects of intestinal mucus and mucins
Malin E. V. Johansson et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Extraintestinal Manifestations of Inflammatory Bowel Disease
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2015)
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
Jimmy Z. Liu et al.
NATURE GENETICS (2015)
The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa
Tawanda Chivese et al.
PLOS ONE (2015)
Crohn's disease-derived monocytes fail to induce Paneth cell defensins
Lioba F. Courth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Role and species-specific expression of colon T cell homing receptor GPR15 in colitis
Linh P. Nguyen et al.
NATURE IMMUNOLOGY (2015)
The Treatment-Naive Microbiome in New-Onset Crohn's Disease
Dirk Gevers et al.
CELL HOST & MICROBE (2014)
Genetic Variants Synthesize to Produce Paneth Cell Phenotypes That Define Subtypes of Crohn's Disease
Kelli L. VanDussen et al.
GASTROENTEROLOGY (2014)
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic et al.
GASTROENTEROLOGY (2014)
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Roberta Caruso et al.
IMMUNITY (2014)
Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome
Marjorie De la Fuente et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes
Mireia Lopez-Siles et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature
Yael Haberman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Lymphatic transport of high-density lipoproteins and chylomicrons
Gwendalyn J. Randolph et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
IL-22-producing CD4+cells are depleted in actively inflamed colitis tissue
J. M. Leung et al.
MUCOSAL IMMUNOLOGY (2014)
A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3
Aditya Murthy et al.
NATURE (2014)
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
Georgina L. Hold et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Smoking does influence disease behaviour and impacts the need for therapy in Crohns disease in the biologic era
T. Nunes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Maureen J. Ostaff et al.
EMBO MOLECULAR MEDICINE (2013)
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project
Isabelle Cleynen et al.
GUT (2013)
Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease
Lea Isabell Kredel et al.
GUT (2013)
Decreased Lymphatic Vessel Density Is Associated With Postoperative Endoscopic Recurrence in Crohn's Disease
Jean-Francois Rahier et al.
INFLAMMATORY BOWEL DISEASES (2013)
Human colonic mucus is a reservoir for antimicrobial peptides
Lena Antoni et al.
Journal of Crohns & Colitis (2013)
Paneth cells as a site of origin for intestinal inflammation
Timon E. Adolph et al.
NATURE (2013)
Extraintestinal manifestations and complications in IBD
Claudia Ott et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa
Sangwon V. Kim et al.
SCIENCE (2013)
Correlation of MMP-3 and MMP-9 with Crohn's Disease Activity in Children
Anna Kofla-Dlubacz et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
Laurent Peyrin-Biroulet et al.
GUT (2012)
Mesenteric fat in Crohn's disease: the hot spot of inflammation?
Britta Siegmund
GUT (2012)
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
Alessandra Zulian et al.
GUT (2012)
Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases
J. Verdier et al.
INFLAMMATORY BOWEL DISEASES (2012)
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Kirsten Boonstra et al.
INFLAMMATORY BOWEL DISEASES (2012)
Serological antibodies in inflammatory bowel disease: A systematic review
Lani Prideaux et al.
INFLAMMATORY BOWEL DISEASES (2012)
Mesenteric fat-control site for bacterial translocation in colitis?
A. Batra et al.
MUCOSAL IMMUNOLOGY (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Inflammatory Bowel Diseases Phenotype, C. difficile and NOD2 Genotype Are Associated with Shifts in Human Ileum Associated Microbial Composition
Ellen Li et al.
PLOS ONE (2012)
Human α-Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets
Hiutung Chu et al.
SCIENCE (2012)
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10-to 19-year-old age bracket (1988-2007)
V. Chouraki et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Nod2 is essential for temporal development of intestinal microbial communities
Ateequr Rehman et al.
GUT (2011)
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
Gregory F. Sonnenberg et al.
NATURE IMMUNOLOGY (2011)
Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
Charles L. Bevins et al.
NATURE REVIEWS MICROBIOLOGY (2011)
A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
Ben P. Willing et al.
GASTROENTEROLOGY (2010)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Predictive Value of Epithelial Gene Expression Profiles for Response to Infliximab in Crohn's Disease
Ingrid Arijs et al.
INFLAMMATORY BOWEL DISEASES (2010)
The final steps of integrin activation: the end game
Sanford J. Shattil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
Laurent Peyrin-Biroulet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
I. Arijs et al.
GUT (2009)
Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort
Peter Laszlo Lakatos et al.
INFLAMMATORY BOWEL DISEASES (2009)
Twin Studies Reveal Specific Imbalances in the Mucosa-associated Microbiota of Patients with Ileal Crohn's Disease
Ben Willing et al.
INFLAMMATORY BOWEL DISEASES (2009)
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Geethanjali Pickert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Integrin Function in T-Cell Homing to Lymphoid and Nonlymphoid Sites: Getting There and Staying There
Christopher C. DeNucci et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis
Julie A. Cornish et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
Arthur Kaser et al.
CELL (2008)
Extraintestinal manifestations of inflammatory bowel disease
S. Ardizzone et al.
DIGESTIVE AND LIVER DISEASE (2008)
Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
L. A. Simms et al.
GUT (2008)
The biological functions of T helper 17 cell effector cytokines in inflammation
Wenjun Ouyang et al.
IMMUNITY (2008)
Clinical and Molecular Characteristics of Isolated Colonic Crohn's Disease
Laura Hancock et al.
INFLAMMATORY BOWEL DISEASES (2008)
Molecular analysis of the gut microbiota of identical twins with Crohn's disease
Johan Dicksved et al.
ISME JOURNAL (2008)
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
Ken Cadwell et al.
NATURE (2008)
Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases - A cohort study of 2402 patients
David Farhi et al.
MEDICINE (2008)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The incidence of Crohn's disease in Cardiff over the last 75 years: An update for 1996-2005
S. Gunesh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Adherent-invasive Escherichia coli in inflammatory bowel disease
Nathalie Rolhion et al.
INFLAMMATORY BOWEL DISEASES (2007)
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W. J. Sandborn et al.
GUT (2007)
Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum
Martin Baumgart et al.
ISME JOURNAL (2007)
Denatured human α-defensin attenuates the bactericidal activity and the stability against enzymatic digestion
Hiroki Tanabe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease
Nicolas Barnich et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The role of Escherichia coli in inflammatory bowel disease
Jonathan M. Rhodes
GUT (2007)
Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro
Sonia Meconi et al.
CELLULAR MICROBIOLOGY (2007)
Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification
Marian C. Aldhous et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al.
NATURE GENETICS (2007)
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21
G. Monteleone et al.
GUT (2006)
Is defective lymphatic drainage a trigger for lymphoid neogenesis?
Olivier Thaunat et al.
TRENDS IN IMMUNOLOGY (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
Juergen Schauber et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
S Brand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages
MA Bringer et al.
CELLULAR MICROBIOLOGY (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intracellular signalling controlling integrin activation in lymphocytes
T Kinashi
NATURE REVIEWS IMMUNOLOGY (2005)
Interleukin-21 enhances T-helper cell type 1 signaling and interferon-γ production in Crohn's disease
G Monteleone et al.
GASTROENTEROLOGY (2005)
Predictors of response to infliximab in luminal Crohn's disease
D Laharie et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2005)
CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease
B Newman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease
A Darfeuille-Michaud et al.
GASTROENTEROLOGY (2004)
Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis
M Economou et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Serologic testing with ANCA, ASCA, and anti-ompC in children and young adults with Crohn's disease and ulcerative colitis: Diagnostic value and correlation with disease phenotype
A Zholudev et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
J Wehkamp et al.
GUT (2004)
Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells
C Becker et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis
J Wehkamp et al.
INFLAMMATORY BOWEL DISEASES (2003)
Crohn's disease and the NOD2 gene:: A role for paneth cells
S Lala et al.
GASTROENTEROLOGY (2003)
An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype
E Louis et al.
GUT (2003)
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis
Y Ogura et al.
GUT (2003)
A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease
MS Silverberg et al.
INFLAMMATORY BOWEL DISEASES (2003)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods
RK Linskens et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study
J Hampe et al.
LANCET (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
AP Cuthbert et al.
GASTROENTEROLOGY (2002)
The molecular classification of the clinical manifestations of Crohn's disease
T Ahmad et al.
GASTROENTEROLOGY (2002)
Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans
M Salmi et al.
GASTROENTEROLOGY (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Paneth cell defensins and innate immunity of the small bowel
AJ Ouellette et al.
INFLAMMATORY BOWEL DISEASES (2001)
Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL
EG De La Concha et al.
GASTROENTEROLOGY (2000)
β-defensin expression in human mammary gland epithelia
CR Tunzi et al.
PEDIATRIC RESEARCH (2000)
分享论文
